Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthcare Services (HCSG) Long-Term Deferred Tax (2016 - 2025)

Healthcare Services (HCSG) has disclosed Long-Term Deferred Tax for 17 consecutive years, with $18.5 million as the latest value for Q4 2025.

  • On a quarterly basis, Long-Term Deferred Tax fell 51.61% to $18.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $18.5 million, a 51.61% decrease, with the full-year FY2025 number at $18.5 million, down 51.61% from a year prior.
  • Long-Term Deferred Tax was $18.5 million for Q4 2025 at Healthcare Services, down from $21.8 million in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $53.1 million in Q2 2025 to a low of $18.5 million in Q4 2025.
  • A 5-year average of $33.7 million and a median of $34.6 million in 2022 define the central range for Long-Term Deferred Tax.
  • Peak YoY movement for Long-Term Deferred Tax: skyrocketed 37.98% in 2024, then crashed 51.61% in 2025.
  • Healthcare Services' Long-Term Deferred Tax stood at $31.5 million in 2021, then fell by 10.14% to $28.3 million in 2022, then increased by 24.31% to $35.2 million in 2023, then increased by 8.36% to $38.2 million in 2024, then plummeted by 51.61% to $18.5 million in 2025.
  • Per Business Quant, the three most recent readings for HCSG's Long-Term Deferred Tax are $18.5 million (Q4 2025), $21.8 million (Q3 2025), and $53.1 million (Q2 2025).